$0.9064
-0.0537-5.59%
Last update: Oct 26, 4:47 PM
Marker Therapeutics Inc (MRKR) Stock Price, Quote, News & History
MRKRNASDAQ
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11)
You can purchase shares of Marker Therapeutics (NASDAQ:MRKR) through any online brokerage.
Other companies in Marker Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Marker Therapeutics has a consensus price target of $12.38.
The stock price for Marker Therapeutics (NASDAQ: MRKR) is $0.9245 last updated October 26, 2026 at 4:47 PM EDT.
There are no upcoming dividends for Marker Therapeutics.
Marker Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Marker Therapeutics.
Marker Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor...
